I. A. Hasanov

I. A. Hasanov

Auto-generated profile, based on publicly available information

I. A. Hasanov

Medical Center “Ozone”, Ganja, Azerbaijan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2021 in Laser Medicine
Verified
Journal Article
Closed access
PDF file
JKJ. V. Kosayev
J. V. Kosayev
IHI. A. Hasanov
I. A. Hasanov
NAN. S. Abushov
N. S. Abushov
GTG. T. Taghi-Zada
G. T. Taghi-Zada
ДКДж. В. Косаев
Дж. В. Косаев
Возможности коррекции гемостаза и гемореологии с применением внутривенного лазерного облучения крови и цитокинотерапии в периоперационном периоде при непрямой реваскуляризации у больных с критической ишемией нижних конечностей

30 June 2026 in "The Medicine and Science" scientific-practical journal named after A.Aliyev
Verified
Journal Article
Closed access
Aygun Aliyar AliyarbayovaAygun Aliyar Aliyarbayova
Aygun Aliyar Aliyarbayova
IHI.A. Hasanov
I.A. Hasanov
GUGokhan Unal
Gokhan Unal
SCS. Cinar-Asa
S. Cinar-Asa
Macrophage Migration Inhibitory Factor (MIF) is a key inflammatory cytokine implicated in immune regulation and tumour biology. Its role in lung disease, particularly in relation to tumour differentiation and clinical risk, remains incompletely understood. This study aimed to evaluate the expression pattern of MIF in lung disease using gene expression profiling, assess its variation across histological grades, and determine its association with clinical risk. A secondary data-based exploratory analysis was conducted using microarray gene expression data from 442 lung tissue samples obtained from a publicly available dataset. MIF expression was extracted using probe ID 200799_at from the Affymetrix Human Genome U133A platform. Samples stratified based on histological differentiation into well, moderate, and poorly differentiated groups. Statistical analyses included descriptive statistics, Welch’s t-test, Pearson correlation, and linear regression. MIF expression demonstrated a significant increase with decreasing tumour differentiation, with the highest levels observed in poorly differentiated tumours (11.05±0.68). Independent t-tests confirmed significant differences between all histological groups (p<0.05). However, correlation analysis revealed a weak and non-significant association with clinical risk (r=0.06, p=0.20) and regression analysis indicated minimal predictive power (R²=0.003). MIF expression is significantly associated with tumour differentiation in lung disease but lacks predictive value for clinical risk. These findings suggest that MIF serves as a marker of tumour biology rather than a standalone prognostic biomarker.

26 June 2020 in Klinicheskaia khirurgiia
Verified
Journal Article
Open access
PDF file
JKJ. V. Kosayev
J. V. Kosayev
IHI. A. Hasanov
I. A. Hasanov
NAN. S. Abushov
N. S. Abushov
GTG. T. Tagizade
G. T. Tagizade
INI. L. Namazov
I. L. Namazov
Objective. To study up the possibilities of the cellular immunity correction using intravenous laser irradiation of the blood and cytokinotherapy with roncoleukin in perioperative period while indirect revascularization done in patients with critical ischemia of the lower extremities. Materials and methods. Prospective controlled clinic-laboratory investigation was performed in 162 patients, suffering critical ischemia of the lower extremities on background of distal arterial stenosis (occlusion) and to whom indirect revascularization operations were done. Etiology of the lower extremities critical ischemia were the obliterating atherosclerosis - in 108 (66.7%) patients and obliterating thrombangiitis - in 54 (33.3%) patients. In 56 patients a Degree III was diagnosed, and in 106 patients - IV Degree of chronic ischemia. In perioperative period in 34 patients a standard treatment was performed (Group I), in 32 patients - standard treatment and intravenous laser irradiation of the blood (Group II), in 32 patients - standard treatment and cytokinotherapy with roncolekin (Group III), in 33 patients - standard treatment, intravenous laser irradiation of the blood and cytokinotherapy (Group IV), in 31 patients in a revascularized osteotrepanation with intramedullary laser irradiation - standard treatment, intravenous laser irradiation of the blood and cytokinotherapy (Group V). Parameters of cellular immunity (CD3+, CD4+, CD8+lymphocytes; ratio CD4+/CD8+) and of phagocytosis were studied in dynamics. The cellular immunity indices were compared with identical indices in 48 practically healthy persons (a reference group). Results. While admittance to hospital in patients with critical ischemia of the lower extremities in a distal stenosis (occlusion) the abrupt change of cellular immunity was revealed towards the immune insufficiency. Inclusion of intravenous laser irradiation of the blood and of cytokinotherapy, separately or in combination, into the treatment measures complex of perioperative period in indirect revascularization have leaded towards trustworthy (p < 0.05) elimination of the cellular immunity indices. Correction of cellular immunity trustworthily depended on (p < 0.01-0.001) the treatment factor with moderate (r =0.5- 0.6) correlation. Best results were obtained while joint application of intravenous laser irradiation of the blood and cytokinotherapy in perioperative period in indirect revascularizaation, peculiarly while operation of revascularized osteotrepanation with intramedullary laser irradiation. Conclusion. Application of intravenous laser irradiation of the blood and cytokinotherapy together with standard treatment in perioperative period while doing indirect revascularization corrects the cellular immunity trustworthily in patients, suffering critical arterial ischemia of the lower extremities, and the dynamics of these indices may be used as an objective criterion of the efficacy estimation for the therapy conducted.

10 August 2021 in Laser Medicine
Verified
Journal Article
Closed access
PDF file
JKJ. V. Kosayev
J. V. Kosayev
IKI. A. Khasanov
I. A. Khasanov
NAN. S. Abushov
N. S. Abushov
GTG. T. Taghi-Zade
G. T. Taghi-Zade
ДКДж. В. Косаев
Дж. В. Косаев
Aim:to study the state of lipid metabolism, hemostasis, inflammatory reaction and the potential for their correction after indirect revascularization in patients with distal steno-occlusion of arteries and critical ischemia of lower extremities (critical ILE).Material and methods.Changes in hemostasis and dynamics of its parameters during the complex surgical treatment in 131 patients with critical ILE and distal arterial stenoocclusion were analyzed. To achieve the targeted goals, patients were divided into the following groups: 34 patients had traditional care (control group); 32 patients had intravenous laser blood irradiation in combination with standard therapy (Group I); 32 patients had cytokine therapy with roncoleukin in combination with standard therapy (Group II); 33 patients had intravenous laser blood irradiation combined with cytokine therapy and standard therapy (Group III). Parameters of lipid metabolism were studied in dynamics (total cholesterol, very low density lipoproteins, high density lipoproteins, triglycerides); products of lipid peroxidation (malondialdehydes, conjugates, superoxide dismutase); inflammatory mediators (C-reactive protein, sialic acids, seromucoids, fibrinogen A, circulating immune complexes); hemostatic parameters (fibrinogen, fibrinolytic activity, fibrin degradation products, antithrombin III activity). Hemostatic indices were compared with identical parameters of 48 apparently healthy individuals (reference group).Results.On admission, patients with critical ILE and distal wall occlusion had sharp changes in their lipid metabolism, inflammatory reaction, and hemostasis. Conclusion. The inclusion of intravenous laser blood irradiation and cytokine therapy separately and in combination in a set of therapeutic measures led to the leveling of the studied homeostasis indicators. The best results were obtained in the group where patients had combined perioperative intravenous laser blood irradiation with cytokine therapy in indirect revascularization.

1 August 2023 in Acta Scientific Medical Sciences
Verified
Journal Article
Open access
KJKosaev Jv
Kosaev Jv
IGIbrahimova Gr
Ibrahimova Gr
GRGuliyev Ra
Guliyev Ra
HIHasanov Ia
Hasanov Ia
ANAbushov Ns
Abushov Ns
SFSadikhov Fq
Sadikhov Fq